India, Maldives foreign minister level talks Friday
K’taka: Kalaburagi, Bidar districts record 666 covid cases
Six arrested for highway robbery of around Rs 1 80 lakh
Jain pays surprise visit to LNJP Hospital amid Covid-19 surge
TMC is on way out from Bengal: Anurag Thakur
40-yr-old Covid recovered man jumps to death in front of Express train in Thane
Kerala reports 8,778 new COVID cases, 2,642 recoveries: Health Minister
UP sees over 20k nCoV cases for first time; 68 deaths
UP prepares for 1st phase of panchayat polls in 18 districts on Thursday
Complete lockdown in Chhattisgarh s Bastar to contain coronavirus
Strides Pharma gains 3 per cent on FDA approval for Prednisone Tablets
February 12, 2021
The product will be manufactured at Bengaluru facility
The shares of Strides Pharma Science Limited (Strides) gained 3 per cent during the afternoon trade on Friday after the company announced that it had received approval for Prednisone Tablets USP, 10 mg and 20 mg from the United States Food & Drug Administration (USFDA).
At 1:13 pm, Strides Pharma was trading at ₹895.40 on the BSE, up ₹29.60 or 3.42 per cent.
It hit an intraday high of ₹902.25 and an intraday low of ₹868.45. It opened at ₹873.25 as against the previous close of ₹865.80.
On the NSE, it was trading at ₹895.00, up ₹28.75 or 3.32 per cent. It hit an intraday high of ₹902.00 and an intraday low of ₹866.30.